Med-Chemist

Med-Chemist : "Quintessential Medicinal Chemistry"

Showing posts with label Hyperactivity Disorder (ADHD). Show all posts
Showing posts with label Hyperactivity Disorder (ADHD). Show all posts
Thursday, May 5, 2022

FDA Approves Xelstrym (dextroamphetamine) Transdermal System for the Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD)

›
Noven Pharmaceuticals, Inc., awholly-ownedsubsidiary of Hisamitsu Pharmaceutical Co., Inc., today announced that the U.S. Food and Drug Admi...
›
Home
View web version

Contributors

  • Dr. Umesh..
  • https://www.med-chemist.com
Powered by Blogger.